At 0.5 and 1.0 μM hesperadin, however, we observed a very strong reduction in the duration of the checkpoint, both in low and high nocodazole.
A recent study found that treatment of patient's cells with an FTI did not result in a reduction in DNA DSBs and damage checkpoint signaling, although it significantly reversed the aberrant shape of their nuclei (Liu et al 2006), suggesting that DNA damage accumulation and aberrant nuclear morphology are independent phenotypes arising from prelamin A accumulation in these PSs.
Loss of pVHL, through an uncharacterized mechanism, results in lower levels of the mitotic checkpoint protein Mad2, which alone causes a moderate elevation of levels of aneuploidy but when combined with reduction in expression of another mitotic spindle checkpoint protein, CENP-E, induces a dramatic increase in aneuploidy (Thoma et al, 2009).
Since cells in which endogenous Mps1 was replaced with LAP-Mps1-T676A LAP-Mps1-T676A LAP-Mps1-T676Anashowedivity and a weakened checkpoint, these cells wereduction for vinbility in a clonogenic assay.
Shorter checkpoint intervals cause frequent checkpointing, large number of checkpoints thus resulting in much time spent in checkpoint activity, higher disk space required to store checkpoint images.
pombe genes that are involved in checkpoint responses (Fig. 6).
Nbs1, the SMC1 component of cohesin, and activating transcription factor 2 (ATF2) have been identified as critical ATM targets in the intra-S checkpoint response, 12, 25 and cells in S-phase exposed to DNA damage activate the intra-S phase checkpoint, leading to a transient reduction in DNA synthesis.
Overexpression of Gls2 in cancer cells induced phosphorylation of the protein phosphatase cdc25c, a key regulator in the G2/M checkpoint, together with a significant reduction in p21 and cyclin D1.
However, both mutants displayed increased sensitivity to DNA alkylation damage and increased repair over the vector only cells suggesting that the reduction in chromatin accumulation does not alter the DNA checkpoint response or repair efficiency.
NB7M treatment affects cell-cycle checkpoints in G1-phase, causing reduction in the progression of cells into S- and G2/M-phase.
Cellular hypoxia results in a rapid reduction in ATP levels, activation of G1 phase cell cycle checkpoint, inhibition of DNA replication, decreased protein synthesis, and increased protein degradation.
